best semaglutide companies The Shortage Is Ending: What's Next For Compounded Drugs? GLP-1 Weight Loss Medication -

Manufacturers interested in expanding the number of USP DC categories and/or classes their product is on should submit additional evidence linking its mechanism of action to additional indications

In February 2026, Daewoong signed an exclusive global licensing agreement for commercialization

Over time, I developed plantar fasciitis, and the repeated stabbing pain and stiffness in my heel made even walking uncomfortable

Individual differences in absorption and metabolism could contribute to the variability observed in GLP-1 responses across study participants

To date, the research has considered serum DAO, skin prick test, histamine challenge, fecal histamine, and genetic testing, but all methods have their limitations and are not validated to diagnose histamine intolerance